In vitro human tissue models - moving towards personalized regenerative medicine

Advanced Drug Delivery Reviews

Volumn 63, Issue 4, 2011, Pages 195-196

  Schenke Layland, Katja ^a,b   Nerem, Robert M ^c  

^a FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c EMORY UNIVERSITY   (United States)

Author keywords

Disease in a dish; Induced pluripotent stem cells; Organ culture; Pharmaceutical tests; Stem cells

Indexed keywords

BIOLOGICAL MODEL; CYTOLOGY; DEVELOPMENTAL BIOLOGY; DRUG RESEARCH; EX VIVO STUDY; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; NOTE; ORGAN CULTURE; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TISSUE CULTURE; TISSUE ENGINEERING;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, BIOLOGICAL; ORGAN CULTURE TECHNIQUES; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 79957684206     PISSN: 0169409X     EISSN: 0169409X     Source Type: Journal    
DOI: 10.1016/j.addr.2011.05.001     Document Type: Note

References (11)

1. Sonntag F., Schilling N., Mader K., Gruchow M., Klotzbach U., Lindner G., Horland R., Wagner I., Lauster R., Howitz S., Hoffmann S., Marx U. Design and prototyping of a chip-based multi-micro-organoid culture system for substance testing, predictive to human (substance) exposure. J. Biotechnol. 2010, 148(1):70-75.
2. Huh D., Matthews B.D., Mammoto A., Montoya-Zavala M., Hsin H.Y., Ingber D.E. Reconstituting organ-level lung functions on a chip. Science 2010, 328:1662-1668.
3. Cencic A., Langerholc T. Functional cell models of the gut and their applications in food microbiology - a review. Int. J. Food Microbiol. 2010, 141(Suppl 1):S4-S14.
4. Innovation or stagnation: Challenge and opportunity on the critical path to new medical products. U.S. Food and Drug Administration's (FDA) Challenges and Opportunity Report, March 2004, page 8.
5. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998, 279(15):1200-1205.
6. Baker M. Tissue models: a living system on a chip. Nature 2011, 471(7340):661-665.
7. Pera M.F. Stem cell: the dark side of induced pluripotency. Nature 2011, 471(7336):46-47.
8. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., Hoskins E.E., Kalinichenko V.V., Wells S.I., Zorn A.M., Shroyer N.F., Wells J.M. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470(7332):105-109.
9. Carvajal-Vergara X., Sevilla A., D'Souza S.L., Ang Y.S., Schaniel C., Lee D.F., Yang L., Kaplan A.D., Adler E.D., Rozoy R., Ge Y., Cohen N., Edelmann L.J., Chang B., Waghray A., Su J., Pardo S., Lichtenbelt K.D., Tartaglia M., Gelb B.D., Lemischka I.R. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010, 465(7299):808-812.
10. Lee G., Papapetrou E.P., Kim H., Chambers S.M., Tomishima M.J., Fasano C.A., Ganat Y.M., Menon J., Shimizu F., Viale A., Tabar V., Sadelain M., Studer L. Modelling pathogenesis and treatment of familial dysautonomia using patent-specific iPSCs. Nature 2009, 461(7262):402-406.
11. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flügel L., Dorn T., Goedel A., Höhnke C., Hofmann F., Seyfarth M., Sinnecker D., Schömig A., Laugwitz K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 2010, 363(15):1397-1409.